Expert Review of Vaccines
Volume 23, 2024 - Issue 1
Open access
579
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
Gabiria Pastorea Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, ItalyView further author information
, Jacopo Polverea Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, ItalyView further author information
, Fabio Fiorinoa Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, Italy;b Department of Medicine and Surgery, LUM University “Giuseppe Degennaro”; Casamassima, Bari, ItalyView further author information
, Simone Lucchesia Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, ItalyView further author information
, Giorgio Montesia Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, ItalyView further author information
, Ilaria Rancanc Department of Medical Biotechnologies, University of Siena, Siena, Italy;d Department of Medical Sciences, Infectious and Tropical Diseases Unit, University Hospital of Siena, Siena, ItalyView further author information
, Sara Zirpolia Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, ItalyView further author information
, Arianna Lippic Department of Medical Biotechnologies, University of Siena, Siena, Italy;d Department of Medical Sciences, Infectious and Tropical Diseases Unit, University Hospital of Siena, Siena, ItalyView further author information
, Miriam Durantec Department of Medical Biotechnologies, University of Siena, Siena, ItalyView further author information
, Massimiliano Fabbianic Department of Medical Biotechnologies, University of Siena, Siena, ItalyView further author information
, Mario Tumbarelloc Department of Medical Biotechnologies, University of Siena, Siena, Italy;d Department of Medical Sciences, Infectious and Tropical Diseases Unit, University Hospital of Siena, Siena, ItalyView further author information
, Francesca Montagnanic Department of Medical Biotechnologies, University of Siena, Siena, Italy;d Department of Medical Sciences, Infectious and Tropical Diseases Unit, University Hospital of Siena, Siena, ItalyView further author information
, Donata Medaglinia Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, ItalyView further author information
& Annalisa Ciabattinia Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena, Siena, ItalyCorrespondence[email protected]
View further author information
show allView further author information
Pages 432-444
|
Received 01 Dec 2023, Accepted 19 Mar 2024, Published online: 02 Apr 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.